Empagliflozin Improves Heart Failure Caused by Pressure Overload by Regulating Cardiac Metabolism

被引：0
|
作者：
Li, Xuan
Liu, Jia
Ren, Di
Zhang, Jingwen
Han, Ying
Li, Ji
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10294
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Empagliflozin improves cardiac function in heart failure with reduced ejection fraction independent of loading conditions
    Bo Liang
    Yu-Xiu Zhao
    Ning Gu
    Cardiovascular Diabetology, 19
  • [22] Chronic sympathectomy improves survival and attenuates cardiac dysfunction during the progression of pressure-overload hypertrophy to heart failure
    Perlini, S
    Ferrero, I
    Fallarini, S
    Palladini, G
    Tozzi, R
    Radaelli, A
    Busca, G
    Ferrari, AU
    EUROPEAN HEART JOURNAL, 2003, 24 : 15 - 15
  • [23] Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload
    Packer, Milton
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Sattar, Naveed
    Brueckmann, Martina
    Jamal, Waheed
    Cotton, Daniel
    Iwata, Tomoko
    Zannad, Faiez
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (11) : 1381 - 1392
  • [24] Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure
    Heron, C.
    Dumesnil, A.
    Houssari, M.
    Renet, S.
    Lemarcis, T.
    Lebon, A.
    Godefroy, D.
    Schapman, D.
    Henri, O.
    Riou, G.
    Nicol, L.
    Henry, J. P.
    Valet, M.
    Pieronne-Deperrois, M.
    Ouvrard-Pascaud, A.
    Hagerling, R.
    Chiavelli, H.
    Michel, J. B.
    Mulder, P.
    Fraineau, S.
    Richard, V
    Tardif, V
    Brakenhielm, E.
    CARDIOVASCULAR RESEARCH, 2023, 119 (02) : 492 - 505
  • [25] T Cells Control Cardiac Remodeling in Pressure Overload Induced Heart Failure
    Nevers, Tania
    Salvador, Ane
    Grodecki-Pena, Anna
    Knapp, Andrew
    Velazquez, Francisco
    Aronovitz, Mark
    Kershaw, Tanya
    Blanton, Robert
    Kapur, Navin
    Karas, Richard
    Alcaide, Pilar
    FASEB JOURNAL, 2015, 29
  • [26] TREATMENT OF HYPERTENSIVE HEART FAILURE AND OF HYPERTENSIVE CARDIAC OVERLOAD BY BLOOD PRESSURE REDUCTION
    SMIRK, FH
    HAMILTON, M
    DOYLE, AE
    MCQUEEN, EG
    AMERICAN JOURNAL OF CARDIOLOGY, 1958, 1 (02): : 143 - 153
  • [27] Empagliflozin improves kidney outcomes in patients with heart failure and CKD
    Carney, Ellen F.
    NATURE REVIEWS NEPHROLOGY, 2021, 17 (01) : 14 - 14
  • [28] Empagliflozin directly improves diastolic function in human heart failure
    Pabel, Steffen
    Wagner, Stefan
    Bollenberg, Hannah
    Bengel, Philipp
    Kovacs, Arpad
    Schach, Christian
    Tirilomis, Petros
    Mustroph, Julian
    Renner, Andre
    Gummert, Jan
    Fischer, Thomas
    Van Linthout, Sophie
    Tschoepe, Carsten
    Streckfuss-Boemeke, Katrin
    Hasenfuss, Gerd
    Maier, Lars S.
    Hamdani, Nazha
    Sossalla, Samuel
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (12) : 1690 - 1700
  • [29] Cardiac TIGAR Reduces Myocardial Energetics and Cardiac Functionin the Pressure Overload Heart Failure Model
    Okawa, Yoshifumi
    Hoshino, Atsushi
    Kitani, Tomoya
    Yamanaka, Ryoetsu
    Hato, Daichi
    Honda, Sakiko
    Fushimura, Yohei
    Urata, Ryota
    Minami, Yoshito
    Hashimoto, Shyo
    Matsuki, Ayumi
    Taminishi, Shunta
    Nishiji, Toshiyuki
    Hino, Tomohiro
    Yagi, Nobuichiro
    Iwai-Kanai, Eri
    Matoba, Satoaki
    CIRCULATION RESEARCH, 2019, 125
  • [30] Cardiomyocte cell cycle induction improves the survival in pressure overload induced heart failure
    Toischer, K.
    Huenlich, M.
    Zhan, W.
    Reuter, S. P.
    Maier, L. S.
    Sossalla, S.
    Field, L. J.
    Hasenfuss, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S42 - S42
12345